The glucagon/GLP-1 dual agonist is noninferior to placebo for major adverse cardiovascular events and lowers blood pressure ...

The University of Exeter’s David Halpin, MA, DPhil, explains why GOLD 2026 treats a single COPD exacerbation as a trigger to ...

First-line IVF produced more live births than IUI within 7 months in couples with unexplained infertility.

Michael Mina, MD, PhD, on why babies, immunocompromised patients, and the unvaccinated have the greatest need for a measles ...

Six studies found liver transplant disparities by insurance, region, ethnicity, and sex, plus links between unmet social ...

Most patients with MASH stay on resmetirom at 1 year, but Medicaid coverage was tied to lower odds of filling a first ...

Two decades ago, lung cancer was treated almost exclusively with cytotoxic chemotherapy. Today, immune checkpoint inhibitors anchor treatment regimens across nearly every stage of the disease, ...

Gut-derived bile acids disrupt liver metabolism through LRH-1 before visible damage, pointing to new early biomarkers for ...

In nonobese patients in the ESSENCE trial, semaglutide improved metabolic dysfunction even with modest weight loss of 2% to 5%.

Myeloma risk prediction is strong, but matching each patient to optimal therapy is still being tested, says Nikhil C. Munshi, ...

Phase 3 Viti-Up trials show Rinvoq (upadacitinib) JAK inhibitor boosts facial and body repigmentation in nonsegmental ...

After Pennsylvania began rewarding Medicaid managed care plans for increasing well-child visits among Black infants, rates ...